EMEA (Europe, Middle East and Africa) Drug Screening Market Report 2018

March 2018 | 107 pages | ID: E9D131AE6CDEN
QYResearch

Abstracts

In this report, the EMEA Drug Screening market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Drug Screening for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Drug Screening market competition by top manufacturers/players, with Drug Screening sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alere
• Express Diagnostics
• Laboratory Corporation of America
• MPD
• Quest Diagnostics
• Roche Diagnostics
• Shimadzu
• Siemens Healthcare
• Thermo Fisher Scientific

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Immunoassay Analyzers
• Chromatography
• Breath Analyzers
• Rapid Testing Devices
• Assay Kits and Reagents

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Research Institute
• Biotechnology & Pharmaceutical Companies
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Drug Screening Market Report 2018

1 DRUG SCREENING OVERVIEW

1.1 Product Overview and Scope of Drug Screening
1.2 Classification of Drug Screening
  1.2.1 EMEA Drug Screening Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Drug Screening Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Immunoassay Analyzers
  1.2.4 Chromatography
  1.2.5 Breath Analyzers
  1.2.6 Rapid Testing Devices
  1.2.7 Assay Kits and Reagents
1.3 EMEA Drug Screening Market by Application/End Users
  1.3.1 EMEA Drug Screening Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Research Institute
  1.3.4 Biotechnology & Pharmaceutical Companies
  1.3.5 Other
1.4 EMEA Drug Screening Market by Region
  1.4.1 EMEA Drug Screening Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Drug Screening (2013-2025)
  1.5.1 EMEA Drug Screening Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Drug Screening Revenue and Growth Rate (2013-2025)

2 EMEA DRUG SCREENING COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Drug Screening Market Competition by Players/Manufacturers
  2.1.1 EMEA Drug Screening Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Drug Screening Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Drug Screening Sale Price by Players (2013-2018)
2.2 EMEA Drug Screening (Volume and Value) by Type/Product Category
  2.2.1 EMEA Drug Screening Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Drug Screening Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Drug Screening Sale Price by Type (2013-2018)
2.3 EMEA Drug Screening (Volume) by Application
2.4 EMEA Drug Screening (Volume and Value) by Region
  2.4.1 EMEA Drug Screening Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Drug Screening Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Drug Screening Sales Price by Region (2013-2018)

3 EUROPE DRUG SCREENING (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Drug Screening Sales and Value (2013-2018)
  3.1.1 Europe Drug Screening Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Drug Screening Revenue and Growth Rate (2013-2018)
3.2 Europe Drug Screening Sales and Market Share by Type
3.3 Europe Drug Screening Sales and Market Share by Application
3.4 Europe Drug Screening Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Drug Screening Sales Volume by Countries (2013-2018)
  3.4.2 Europe Drug Screening Revenue by Countries (2013-2018)
  3.4.3 Germany Drug Screening Sales and Growth Rate (2013-2018)
  3.4.4 France Drug Screening Sales and Growth Rate (2013-2018)
  3.4.5 UK Drug Screening Sales and Growth Rate (2013-2018)
  3.4.6 Russia Drug Screening Sales and Growth Rate (2013-2018)
  3.4.7 Italy Drug Screening Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Drug Screening Sales and Growth Rate (2013-2018)

4 MIDDLE EAST DRUG SCREENING (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Drug Screening Sales and Value (2013-2018)
  4.1.1 Middle East Drug Screening Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Drug Screening Revenue and Growth Rate (2013-2018)
4.2 Middle East Drug Screening Sales and Market Share by Type
4.3 Middle East Drug Screening Sales and Market Share by Application
4.4 Middle East Drug Screening Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Drug Screening Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Drug Screening Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Drug Screening Sales and Growth Rate (2013-2018)
  4.4.4 Israel Drug Screening Sales and Growth Rate (2013-2018)
  4.4.5 UAE Drug Screening Sales and Growth Rate (2013-2018)
  4.4.6 Iran Drug Screening Sales and Growth Rate (2013-2018)

5 AFRICA DRUG SCREENING (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Drug Screening Sales and Value (2013-2018)
  5.1.1 Africa Drug Screening Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Drug Screening Revenue and Growth Rate (2013-2018)
5.2 Africa Drug Screening Sales and Market Share by Type
5.3 Africa Drug Screening Sales and Market Share by Application
5.4 Africa Drug Screening Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Drug Screening Sales Volume by Countries (2013-2018)
  5.4.2 Africa Drug Screening Revenue by Countries (2013-2018)
  5.4.3 South Africa Drug Screening Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Drug Screening Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Drug Screening Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Drug Screening Sales and Growth Rate (2013-2018)

6 EMEA DRUG SCREENING MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Alere
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drug Screening Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alere Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Express Diagnostics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Drug Screening Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Express Diagnostics Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Laboratory Corporation of America
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Drug Screening Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Laboratory Corporation of America Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 MPD
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Drug Screening Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 MPD Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Quest Diagnostics
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Drug Screening Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Quest Diagnostics Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Roche Diagnostics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Drug Screening Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Diagnostics Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Shimadzu
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Drug Screening Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shimadzu Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Siemens Healthcare
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Drug Screening Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Siemens Healthcare Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Thermo Fisher Scientific
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Drug Screening Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Thermo Fisher Scientific Drug Screening Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 DRUG SCREENING MANUFACTURING COST ANALYSIS

7.1 Drug Screening Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug Screening

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drug Screening Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug Screening Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DRUG SCREENING MARKET FORECAST (2018-2025)

11.1 EMEA Drug Screening Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Drug Screening Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Drug Screening Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Drug Screening Price and Trend Forecast (2018-2025)
11.2 EMEA Drug Screening Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Drug Screening Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Drug Screening Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Drug Screening Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Drug Screening Sales Forecast by Type (2018-2025)
11.7 EMEA Drug Screening Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drug Screening
Figure EMEA Drug Screening Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Drug Screening Sales Volume Market Share by Type (Product Category) in 2017
Figure Immunoassay Analyzers Product Picture
Figure Chromatography Product Picture
Figure Breath Analyzers Product Picture
Figure Rapid Testing Devices Product Picture
Figure Assay Kits and Reagents Product Picture
Figure EMEA Drug Screening Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Drug Screening by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Research Institute Examples
Table Key Downstream Customer in Research Institute
Figure Biotechnology & Pharmaceutical Companies Examples
Table Key Downstream Customer in Biotechnology & Pharmaceutical Companies
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Drug Screening Market Size (Million USD) by Region (2013-2025)
Figure Europe Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Drug Screening Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Drug Screening Revenue (Million USD) Status and Forecast by Countries
Figure Africa Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Drug Screening Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Drug Screening Sales Volume and Growth Rate (2013-2025)
Figure EMEA Drug Screening Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Drug Screening Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Drug Screening Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Drug Screening Sales Share by Players (2013-2018)
Figure 2017 Drug Screening Sales Share by Players
Figure 2017 Drug Screening Sales Share by Players
Figure EMEA Drug Screening Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Drug Screening Revenue (Million USD) by Players (2013-2018)
Table EMEA Drug Screening Revenue Share by Players (2013-2018)
Table 2017 EMEA Drug Screening Revenue Share by Players
Table 2017 EMEA Drug Screening Revenue Share by Players
Table EMEA Drug Screening Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Drug Screening Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Drug Screening Sales Share by Type (2013-2018)
Figure Sales Market Share of Drug Screening by Type (2013-2018)
Figure EMEA Drug Screening Sales Market Share by Type (2013-2018)
Table EMEA Drug Screening Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Drug Screening Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Drug Screening by Type in 2017
Table EMEA Drug Screening Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Drug Screening Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Drug Screening Sales Share by Application (2013-2018)
Figure Sales Market Share of Drug Screening by Application (2013-2018)
Figure EMEA Drug Screening Sales Market Share by Application in 2017
Table EMEA Drug Screening Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Drug Screening Sales Share by Region (2013-2018)
Figure Sales Market Share of Drug Screening by Region (2013-2018)
Figure EMEA Drug Screening Sales Market Share in 2017
Table EMEA Drug Screening Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Drug Screening Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Drug Screening by Region (2013-2018)
Figure EMEA Drug Screening Revenue Market Share Regions in 2017
Table EMEA Drug Screening Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Drug Screening Revenue and Growth Rate (2013-2018)
Table Europe Drug Screening Sales (K Units) by Type (2013-2018)
Table Europe Drug Screening Market Share by Type (2013-2018)
Figure Europe Drug Screening Market Share by Type in 2017
Table Europe Drug Screening Sales (K Units) by Application (2013-2018)
Table Europe Drug Screening Market Share by Application (2013-2018)
Figure Europe Drug Screening Market Share by Application in 2017
Table Europe Drug Screening Sales (K Units) by Countries (2013-2018)
Table Europe Drug Screening Sales Market Share by Countries (2013-2018)
Figure Europe Drug Screening Sales Market Share by Countries (2013-2018)
Figure Europe Drug Screening Sales Market Share by Countries in 2017
Table Europe Drug Screening Revenue (Million USD) by Countries (2013-2018)
Table Europe Drug Screening Revenue Market Share by Countries (2013-2018)
Figure Europe Drug Screening Revenue Market Share by Countries (2013-2018)
Figure Europe Drug Screening Revenue Market Share by Countries in 2017
Figure Germany Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure France Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure UK Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Drug Screening Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Drug Screening Sales (K Units) by Type (2013-2018)
Table Middle East Drug Screening Market Share by Type (2013-2018)
Figure Middle East Drug Screening Market Share by Type (2013-2018)
Table Middle East Drug Screening Sales (K Units) by Applications (2013-2018)
Table Middle East Drug Screening Market Share by Applications (2013-2018)
Figure Middle East Drug Screening Sales Market Share by Application in 2017
Table Middle East Drug Screening Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Drug Screening Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Drug Screening Sales Volume Market Share by Countries in 2017
Table Middle East Drug Screening Revenue (Million USD) by Countries (2013-2018)
Table Middle East Drug Screening Revenue Market Share by Countries (2013-2018)
Figure Middle East Drug Screening Revenue Market Share by Countries (2013-2018)
Figure Middle East Drug Screening Revenue Market Share by Countries in 2017
Figure Saudi Arabia Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Drug Screening Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Drug Screening Sales (K Units) by Type (2013-2018)
Table Africa Drug Screening Sales Market Share by Type (2013-2018)
Figure Africa Drug Screening Sales Market Share by Type (2013-2018)
Figure Africa Drug Screening Sales Market Share by Type in 2017
Table Africa Drug Screening Sales (K Units) by Application (2013-2018)
Table Africa Drug Screening Sales Market Share by Application (2013-2018)
Figure Africa Drug Screening Sales Market Share by Application (2013-2018)
Table Africa Drug Screening Sales Volume (K Units) by Countries (2013-2018)
Table Africa Drug Screening Sales Market Share by Countries (2013-2018)
Figure Africa Drug Screening Sales Market Share by Countries (2013-2018)
Figure Africa Drug Screening Sales Market Share by Countries in 2017
Table Africa Drug Screening Revenue (Million USD) by Countries (2013-2018)
Table Africa Drug Screening Revenue Market Share by Countries (2013-2018)
Figure Africa Drug Screening Revenue Market Share by Countries (2013-2018)
Figure Africa Drug Screening Revenue Market Share by Countries in 2017
Figure South Africa Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Table Alere Drug Screening Basic Information List
Table Alere Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alere Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Alere Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Alere Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Express Diagnostics Drug Screening Basic Information List
Table Express Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Express Diagnostics Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Express Diagnostics Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Express Diagnostics Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Laboratory Corporation of America Drug Screening Basic Information List
Table Laboratory Corporation of America Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Laboratory Corporation of America Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Laboratory Corporation of America Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Laboratory Corporation of America Drug Screening Revenue Market Share in EMEA (2013-2018)
Table MPD Drug Screening Basic Information List
Table MPD Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure MPD Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure MPD Drug Screening Sales Market Share in EMEA (2013-2018)
Figure MPD Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Quest Diagnostics Drug Screening Basic Information List
Table Quest Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Quest Diagnostics Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Quest Diagnostics Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Quest Diagnostics Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Roche Diagnostics Drug Screening Basic Information List
Table Roche Diagnostics Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Diagnostics Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Roche Diagnostics Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Roche Diagnostics Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Shimadzu Drug Screening Basic Information List
Table Shimadzu Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shimadzu Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Shimadzu Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Shimadzu Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Siemens Healthcare Drug Screening Basic Information List
Table Siemens Healthcare Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Siemens Healthcare Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Siemens Healthcare Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Siemens Healthcare Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Thermo Fisher Scientific Drug Screening Basic Information List
Table Thermo Fisher Scientific Drug Screening Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Thermo Fisher Scientific Drug Screening Sales (K Units) and Growth Rate (2013-2018)
Figure Thermo Fisher Scientific Drug Screening Sales Market Share in EMEA (2013-2018)
Figure Thermo Fisher Scientific Drug Screening Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug Screening
Figure Manufacturing Process Analysis of Drug Screening
Figure Drug Screening Industrial Chain Analysis
Table Raw Materials Sources of Drug Screening Major Manufacturers in 2017
Table Major Buyers of Drug Screening
Table Distributors/Traders List
Figure EMEA Drug Screening Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Drug Screening Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Drug Screening Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Drug Screening Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Drug Screening Sales Market Share Forecast by Region (2018-2025)
Table EMEA Drug Screening Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Drug Screening Revenue Market Share Forecast by Region (2018-2025)
Table Europe Drug Screening Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Drug Screening Sales Market Share Forecast by Countries (2018-2025)
Table Europe Drug Screening Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Drug Screening Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Drug Screening Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Drug Screening Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Drug Screening Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Drug Screening Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Drug Screening Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Drug Screening Sales Market Share Forecast by Countries (2018-2025)
Table Africa Drug Screening Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Drug Screening Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Drug Screening Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Drug Screening Sales Market Share Forecast by Type (2018-2025)
Table EMEA Drug Screening Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Drug Screening Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources